光敏纳米颗粒修饰的巨噬细胞对乳腺癌免疫微环境的影响

国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
乳腺癌的靶向治疗近年来受到了广泛的关注,然而由于肿瘤复杂的免疫微环境,靶向治疗的方法拓展和联合应用还有待新的突破。我们在前期研究中优化并制备了携带光动力学治疗用光敏剂的纳米颗粒,利用巨噬细胞能被招募并作用于肿瘤免疫微环境的天然特性,有机联合了乳腺癌免疫微环境重构调节和深部靶向光动力学治疗。本研究拟:1)利用细胞代谢修饰工程学设计出表面表达特殊分子(如环状RGD肽段)修饰型的巨噬细胞,利用其内吞作用携载治疗物质(如光敏剂),形成靶向乳腺癌免疫微环境的治疗系统;2)深入研究代谢修饰型巨噬细胞治疗系统对乳腺癌免疫微环境的重构影响和作用机制;3)依据前期我们对乳腺癌免疫微环境中干性及炎性的研究成果,进一步开发多种针对乳腺癌免疫环境调控的修饰型巨噬细胞治疗系统,并验证其治疗效果。本研究不仅为乳腺癌免疫调控的机制研究建立了更加高效的工具,同时改造乳腺癌微环境的免疫治疗提供新的概念和临床转化方法。
英文摘要
Targeted therapy for breast cancer has received widespread attention in recent years. However, due to the complex immune microenvironment of tumor, developing the methods and combining more strategies should be made breakthroughs in the targeted therapy. In the previous study, we optimized the photosensitizer-loaded nanoparticles, and targeted deep tumor tissues using the macrophage biological nature of being recruited in and influencing the tumor immune microenvironment. This system combines breast cancer immune microenvironment remodeling and targeted photodynamic therapy. In this research, we plan to: 1) Design a modified macrophage with the surface-linked molecular (such as cyclic RGD peptide) based on the cellular metabolism modification engineering and complete the targeted transport system by therapeutic substance (such as photosensitizer) loading using macrophage endocytosis; 2) Study the regulatory function of the system by surface modified macrophages based on cellular metabolism in breast cancer immune microenvironment remodeling; 3) Based on the previous research on the stemness and inflammatory properties of breast cancer immune microenvironment, develop more macrophage transport systems which can target the breast cancer immune microenvironment and verify their effect. Our research establishes more optimized tools for the study of breast cancer immune regulation mechanisms, and brings theoretical foundation and new approach to the transformation of breast cancer immunotherapy.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis.
系统性 CRISPR 筛选揭示了 IL-20/IL20RA 介导的免疫串扰可预防卵巢癌转移。
DOI:10.7554/elife.66222
发表时间:2021-06-11
期刊:eLife
影响因子:7.7
作者:Li J;Qin X;Shi J;Wang X;Li T;Xu M;Chen X;Zhao Y;Han J;Piao Y;Zhang W;Qu P;Wang L;Xiang R;Shi Y
通讯作者:Shi Y
DOI:10.1158/1541-7786.mcr-22-0333
发表时间:2022
期刊:Molecular Cancer Research
影响因子:--
作者:Shiqing Wang;Yuxin Liu;Siyu Li;Yanan Chen;Yanhua Liu;Jie Yan;Jiayi Wu;Jia Li;Longlong Wang;Rong Xiang;Yi Shi;Xuan Qin;Shuang Yang
通讯作者:Shuang Yang
Enhancement of tumor immunogenicity by the introduction of non- proteinogenic amino acid azetidine-2-carboxylic acid
通过引入非蛋白氨基酸氮杂环丁烷-2-羧酸增强肿瘤免疫原性
DOI:10.1080/2162402x.2022.2097460
发表时间:2022
期刊:OncoImmunology
影响因子:7.2
作者:Siyu Li;Shi;Baorui Tian;Na Li;Yanan Chen;Yanhua Liu;Weijun Su;Yan Fan;Yongjun Piao;Jia Li;Longlong Wang;Jin Zhao;Shu Wang;Yi Shi;R. Xiang
通讯作者:R. Xiang
Generation of triacyl lipopeptide-modified glycoproteins by metabolic glycoengineering as the neoantigen to boost anti-tumor immune response.
通过代谢糖工程生成三酰脂肽修饰的糖蛋白作为新抗原来增强抗肿瘤免疫反应。
DOI:10.7150/thno.60211
发表时间:2021
期刊:Theranostics
影响因子:12.4
作者:Zhao Y;Li S;Lv J;Liu Y;Chen Y;Liu Y;Chen X;Li J;Qin X;Wang X;Shi J;Shi Y;Xiang R
通讯作者:Xiang R
DOI:10.7150/thno.58956
发表时间:2021
期刊:Theranostics
影响因子:12.4
作者:Qin X;Li J;Wang S;Lv J;Luan F;Liu Y;Chen Y;Chen X;Zhao Y;Zhu J;Piao Y;Zhang W;Shi Y;Xiang R;Qu P;Wang L
通讯作者:Wang L
Serotonin信号轴在精神压力促卵巢癌腹腔扩散中的作用机制及靶向干预
- 批准号:82373033
- 项目类别:面上项目
- 资助金额:49万元
- 批准年份:2023
- 负责人:向荣
- 依托单位:
KDM6B对弥漫性大B细胞淋巴瘤发生发展的调节机制研究
- 批准号:81470354
- 项目类别:面上项目
- 资助金额:75.0万元
- 批准年份:2014
- 负责人:向荣
- 依托单位:
新型pH敏感口服纳米DNA疫苗的研制
- 批准号:81273331
- 项目类别:面上项目
- 资助金额:75.0万元
- 批准年份:2012
- 负责人:向荣
- 依托单位:
肿瘤微环境对肿瘤干细胞的调节机制及其新的治疗策略
- 批准号:30830096
- 项目类别:重点项目
- 资助金额:160.0万元
- 批准年份:2008
- 负责人:向荣
- 依托单位:
国内基金
海外基金
